Choose the collection model that fits
We assess retrospective and banked sourcing alongside prospective, project-specific collections. Healthy and disease cohorts, matched materials and longitudinal programmes can be explored within the agreed permissions and operational scope.
- Banked and retrospective materials with available, permitted clinical context.
- Prospective collections designed around an agreed research requirement.
- Matched and longitudinal programmes, including repeat timepoints and linked materials.
Explore a broad range of research materials
Material type, suitability, associated information and availability are confirmed during feasibility. This is a capability overview, not a live stock catalogue.
- Whole blood, serum, plasma, peripheral blood mononuclear cells (PBMCs) and buffy coat.
- FFPE blocks and slides; fresh, fresh-frozen and cryopreserved tissue.
- Tumour, normal and matched adjacent-normal material.
- DNA and RNA sourcing or preparation within the agreed laboratory scope.
- Urine, saliva, cerebrospinal fluid, ascitic fluid and other selected research matrices.
- Bone marrow and specialist collections when clinically and operationally appropriate.
- Matched combinations of tissue, blood fractions and other materials with agreed clinical information.
Connect materials with useful context
Depending on availability and permission, clinical annotation can include diagnosis, histology, stage, grade, treatment context, biomarkers and follow-up. The project specifies the requested fields, coding approach and documentation expectations.
Define acceptance and delivery together
The agreed scope identifies the collection or sourcing route, roles, relevant quality review, permitted use and transfer arrangements. Biobanking, pathology, laboratory and logistics support can be coordinated around the project.